Risk stratification of HBV infection in Asia-Pacific region-Reference-Cited by-同舟云学术

Risk stratification of HBV infection in Asia-Pacific region

Published:2014 Issue:3 Volume:20 Page:223
ISSN:2287-2728
Container-title:Clinical and Molecular Hepatology
language:en
Short-container-title:Clin Mol Hepatol

Author:

Kao Jia-Horng¹

Affiliation:

1. Department of Internal Medicine, National Taiwan University Hospital, Graduate Institute of Clinical Medicine, Hepatitis Research Center, and Department of Medical Research, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei, Taiwan.

Publisher

The Korean Association for the Study of the Liver

Subject

Molecular Biology,Hepatology

Link

http://synapse.koreamed.org/pdf/10.3350/cmh.2014.20.3.223

Reference36 articles.

1. Global control of hepatitis B virus infection

2. Recent Advances in the Research of Hepatitis B Virus-Related Hepatocellular Carcinoma

3. Hepatitis B Virus Genotypes and Hepatocellular Carcinoma in Taiwan

4. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B

5. Hepatitis B viral factors and treatment responses in chronic hepatitis B

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel mechanistic insights – A brand new Era for anti-HBV drugs;European Journal of Medicinal Chemistry;2024-12

2. Development and validation of HBV surveillance models using big data and machine learning;Annals of Medicine;2024-02-10

3. Low host immune pressure may be associated with the development of hepatocellular carcinoma: a longitudinal analysis of complete genomes of the HBV 1762T, 1764A mutant;Frontiers in Oncology;2023-08-23

4. A cautionary note to hepatitis B e antigen (HBeAg)‐negative test results in pregnant women in an area prevalent of HBeAg‐negative chronic hepatitis B;Journal of Medical Virology;2022-09-14

5. Changing risk factors for hepatocellular carcinoma in hyperendemic regions in the era of universal hepatitis B vaccination;Cancer Epidemiology;2020-08